Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs JDOC overlap: 64% of top holdings shared

Bottom line

How much do PHSYX and JDOC overlap?

64% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 71.9% of PHSYX's assets and 57.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PHSYXJDOC
Weight overlap (top 25)64%
Shared holdings15
Weight in shared holdings71.9%57.2%
Total positions11561
Expense ratio0.79%0.65%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings PHSYX and JDOC have in common

Holding% of PHSYX% of JDOCOverlap
Eli Lilly & Co.13.15%7.76%7.76%
Johnson & Johnson8.46%4.82%4.82%
UnitedHealth Group, Inc.6.93%5.85%5.85%
AbbVie, Inc.6.05%7.85%6.05%
Novartis AG5.13%1.60%1.60%
Merck & Co., Inc.4.88%4.82%4.82%
AstraZeneca plc4.67%3.76%3.76%
Thermo Fisher Scientific, Inc.4.50%3.73%3.73%
Intuitive Surgical, Inc.4.04%1.93%1.93%
Edwards Lifesciences Corp.2.80%1.73%1.73%
Roche Holding AG2.79%2.82%2.79%
CVS Health Corp.2.74%2.83%2.74%
Cardinal Health, Inc.2.12%1.51%1.51%
Novo Nordisk A/S1.90%2.61%1.90%
Bristol-Myers Squibb Co.1.75%3.57%1.75%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. Sanofi SA — 3.23%
  2. Gilead Sciences, Inc. — 2.63%
  3. McKesson Corp. — 2.14%
  4. Vertex Pharmaceuticals, Inc. — 1.97%
  5. Boston Scientific Corp. — 1.80%
  6. Dexcom, Inc. — 1.64%
  7. Hoya Corp. — 1.52%
  8. Putnam Short Term Investment Fund — 1.35%
  9. HCA Healthcare, Inc. — 1.18%
  10. Amgen, Inc. — 1.11%

Only in JDOC

  1. Abbott Laboratories — 3.11%
  2. GSK plc — 2.47%
  3. Stryker Corp. — 2.23%
  4. Danaher Corp. — 2.16%
  5. Cencora, Inc. — 2.07%
  6. Argenx SE — 2.06%
  7. IQVIA Holdings, Inc. — 1.71%
  8. Teva Pharmaceutical Industries Ltd. — 1.60%
  9. Regeneron Pharmaceuticals, Inc. — 1.60%
  10. Biogen, Inc. — 1.56%

Asset mix

Asset typePHSYXJDOC
Stocks98.2%99.2%
Other1.4%—
Cash & short-term funds0.6%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryPHSYXJDOC
US76.2%75.2%
CH7.9%4.4%
GB6.4%6.2%
DK2.4%4.0%
FR3.2%—
JP2.4%2.5%
NL1.2%2.4%
DE—1.9%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PHSYX and JDOC overlap?
About 64% by weight. 15 securities appear in both funds' top 25 holdings; they make up 71.9% of PHSYX's assets and 57.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and JDOC have in common?
The largest shared holdings are Eli Lilly & Co., AbbVie, Inc., UnitedHealth Group, Inc., Merck & Co., Inc., Johnson & Johnson.
Should I own both PHSYX and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or JDOC?
PHSYX is broader, with 115 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.